PortfoliosLab logoPortfoliosLab logo
MED vs. VFC
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

MED vs. VFC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Medifast, Inc. (MED) and V.F. Corporation (VFC). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, MED achieves a -0.56% return, which is significantly higher than VFC's -5.48% return. Over the past 10 years, MED has outperformed VFC with an annualized return of -8.13%, while VFC has yielded a comparatively lower -8.92% annualized return.


MED

1D
-3.63%
1M
-15.65%
YTD
-0.56%
6M
-4.75%
1Y
-20.21%
3Y*
-49.98%
5Y*
-46.74%
10Y*
-8.13%

VFC

1D
-0.70%
1M
1.80%
YTD
-5.48%
6M
-7.28%
1Y
50.49%
3Y*
0.01%
5Y*
-24.49%
10Y*
-8.92%
*Multi-year figures are annualized to reflect compound growth (CAGR)

MED vs. VFC - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
MED
Medifast, Inc.
-0.56%-39.39%-73.79%-38.34%-42.31%9.36%86.18%-9.73%82.11%72.33%
VFC
V.F. Corporation
-5.48%-13.83%16.64%-28.51%-60.38%-12.05%-12.00%51.70%-1.33%42.78%

Correlation

The correlation between MED and VFC is 0.21, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.21

Correlation (3Y)
Calculated over the trailing 3-year period

0.30

Correlation (5Y)
Calculated over the trailing 5-year period

0.33

Correlation (10Y)
Calculated over the trailing 10-year period

0.33

Correlation (All Time)
Calculated using the full available price history since Dec 31, 1993

0.20

The correlation between MED and VFC shifts across timeframes, from 0.20 (all time) to 0.33 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

EPS

MED:

-$1.82

VFC:

$0.57

PS Ratio

MED:

0.34

VFC:

0.69

Total Revenue (TTM)

MED:

$346.10M

VFC:

$9.58B

Gross Profit (TTM)

MED:

$242.70M

VFC:

$5.16B

EBITDA (TTM)

MED:

-$3.86M

VFC:

$961.05M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

MED vs. VFC — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MED
MED Risk / Return Rank: 2222
Overall Rank
MED Sharpe Ratio Rank: 2121
Sharpe Ratio Rank
MED Sortino Ratio Rank: 1919
Sortino Ratio Rank
MED Omega Ratio Rank: 2121
Omega Ratio Rank
MED Calmar Ratio Rank: 2323
Calmar Ratio Rank
MED Martin Ratio Rank: 2424
Martin Ratio Rank

VFC
VFC Risk / Return Rank: 7272
Overall Rank
VFC Sharpe Ratio Rank: 7474
Sharpe Ratio Rank
VFC Sortino Ratio Rank: 7070
Sortino Ratio Rank
VFC Omega Ratio Rank: 6868
Omega Ratio Rank
VFC Calmar Ratio Rank: 7676
Calmar Ratio Rank
VFC Martin Ratio Rank: 7474
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

MED vs. VFC - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Medifast, Inc. (MED) and V.F. Corporation (VFC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


MEDVFCDifference
Sharpe ratioReturn per unit of total volatility

-1.54

Sortino ratioReturn per unit of downside risk

-2.22

Omega ratioGain probability vs. loss probability

0.94

1.20

-0.26

Calmar ratioReturn relative to maximum drawdown

-0.54

1.98

-2.53

Martin ratioReturn relative to average drawdown

-0.91

4.39

-5.30

MED vs. VFC - Sharpe Ratio Comparison

The current MED Sharpe Ratio is -0.49, which is lower than the VFC Sharpe Ratio of 1.05. The chart below compares the historical Sharpe Ratios of MED and VFC, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

MED vs. VFC - Drawdown Comparison

The maximum MED drawdown since its inception was -98.40%, which is greater than VFC's maximum drawdown of -88.41%. Use the drawdown chart below to compare losses from any high point for MED and VFC.


Loading charts...

Drawdown Indicators


MEDVFCDifference

Max Drawdown

Largest peak-to-trough decline

-98.40%

-88.41%

-9.99%

Max Drawdown (1Y)

Largest decline over 1 year

-37.39%

-25.57%

-11.82%

Max Drawdown (3Y)

Largest decline over 3 years

-90.91%

-63.66%

-27.25%

Max Drawdown (5Y)

Largest decline over 5 years

-96.29%

-86.78%

-9.51%

Max Drawdown (10Y)

Largest decline over 10 years

-96.76%

-88.41%

-8.35%

Current Drawdown

Current decline from peak

-96.39%

-79.29%

-17.10%

Average Drawdown

Average peak-to-trough decline

-50.87%

-21.70%

-29.17%

Ulcer Index

Depth and duration of drawdowns from previous peaks

22.20%

11.53%

+10.67%

Volatility

MED vs. VFC - Volatility Comparison

The current volatility for Medifast, Inc. (MED) is 10.79%, while V.F. Corporation (VFC) has a volatility of 13.65%. This indicates that MED experiences smaller price fluctuations and is considered to be less risky than VFC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


MEDVFCDifference

Volatility (1M)

Calculated over the trailing 1-month period

10.79%

13.65%

-2.86%

Volatility (6M)

Calculated over the trailing 6-month period

31.95%

31.10%

+0.85%

Volatility (1Y)

Calculated over the trailing 1-year period

41.90%

48.36%

-6.46%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

45.28%

53.67%

-8.39%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

47.74%

44.99%

+2.75%

Dividends

MED vs. VFC - Dividend Comparison

MED has not paid dividends to shareholders, while VFC's dividend yield for the trailing twelve months is around 2.13%.


PositionTTM20252024202320222021202020192018201720162015
MED
Medifast, Inc.
0.00%0.00%0.00%7.36%5.69%2.71%2.30%3.08%1.75%2.06%2.57%0.82%
VFC
V.F. Corporation
2.13%1.99%1.68%5.27%7.28%2.69%2.26%1.91%2.65%2.32%2.87%2.14%

Financials

MED vs. VFC - Financials Comparison

This section allows you to compare key financial metrics between Medifast, Inc. and V.F. Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.001.00B2.00B3.00B4.00B20222023202420252026
76.04M
2.88B
(MED) Total Revenue
(VFC) Total Revenue
Values in USD except per share items

MED vs. VFC - Profitability Comparison

The chart below illustrates the profitability comparison between Medifast, Inc. and V.F. Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

50.0%55.0%60.0%65.0%70.0%75.0%20222023202420252026
68.1%
55.6%
Portfolio components
MED - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Medifast, Inc. reported a gross profit of 51.76M and revenue of 76.04M. Therefore, the gross margin over that period was 68.1%.

VFC - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, V.F. Corporation reported a gross profit of 1.60B and revenue of 2.88B. Therefore, the gross margin over that period was 55.6%.

MED - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Medifast, Inc. reported an operating income of -3.30M and revenue of 76.04M, resulting in an operating margin of -4.3%.

VFC - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, V.F. Corporation reported an operating income of 289.05M and revenue of 2.88B, resulting in an operating margin of 10.1%.

MED - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Medifast, Inc. reported a net income of -2.12M and revenue of 76.04M, resulting in a net margin of -2.8%.

VFC - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, V.F. Corporation reported a net income of 300.85M and revenue of 2.88B, resulting in a net margin of 10.5%.


Frequently Asked Questions


MED and VFC have a correlation of 0.21, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

VFC has higher volatility (13.65%) compared to MED (10.79%). In terms of maximum drawdown, MED dropped -98.40% vs VFC's -88.41%.

VFC currently has the higher Sharpe Ratio (1.05 vs -0.49), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for MED and VFC

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer